CME Group Inc. (NASDAQ:CME) insider Kimberly S. Taylor sold 7,400 shares of the firm’s stock in a transaction dated Tuesday, June 13th. The shares were sold at an average price of $125.95, for a total transaction of $932,030.00. Following the completion of the transaction, the insider now directly owns 115,330 shares in the company, valued at approximately $14,525,813.50. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Shares of CME Group Inc. (NASDAQ CME) opened at 126.18 on Monday. The firm has a market capitalization of $42.87 billion, a P/E ratio of 27.31 and a beta of 0.75. CME Group Inc. has a 12 month low of $92.29 and a 12 month high of $127.66. The company has a 50 day moving average of $118.96 and a 200-day moving average of $119.41.
CME Group (NASDAQ:CME) last announced its earnings results on Thursday, April 27th. The financial services provider reported $1.22 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.02. CME Group had a return on equity of 7.43% and a net margin of 43.62%. The business had revenue of $929 million for the quarter, compared to analysts’ expectations of $932.06 million. During the same period in the prior year, the business posted $1.15 earnings per share. The firm’s revenue was down .5% on a year-over-year basis. Analysts predict that CME Group Inc. will post $4.85 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, June 26th. Investors of record on Friday, June 9th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 2.09%. The ex-dividend date is Wednesday, June 7th. CME Group’s payout ratio is presently 57.14%.
ILLEGAL ACTIVITY WARNING: This article was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://sportsperspectives.com/2017/06/19/kimberly-s-taylor-sells-7400-shares-of-cme-group-inc-cme-stock.html.
A number of hedge funds have recently made changes to their positions in CME. BlackRock Inc. boosted its stake in shares of CME Group by 2,172.6% in the first quarter. BlackRock Inc. now owns 27,265,611 shares of the financial services provider’s stock valued at $3,239,152,000 after buying an additional 26,065,883 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of CME Group by 3.8% in the first quarter. Vanguard Group Inc. now owns 22,232,434 shares of the financial services provider’s stock valued at $2,641,214,000 after buying an additional 806,282 shares during the last quarter. State Street Corp boosted its stake in shares of CME Group by 5.7% in the fourth quarter. State Street Corp now owns 17,986,325 shares of the financial services provider’s stock valued at $2,084,930,000 after buying an additional 977,421 shares during the last quarter. Edgewood Management LLC boosted its stake in shares of CME Group by 26.4% in the first quarter. Edgewood Management LLC now owns 7,228,349 shares of the financial services provider’s stock valued at $858,728,000 after buying an additional 1,511,753 shares during the last quarter. Finally, FMR LLC boosted its stake in shares of CME Group by 5.4% in the fourth quarter. FMR LLC now owns 7,226,868 shares of the financial services provider’s stock valued at $833,618,000 after buying an additional 371,705 shares during the last quarter. Institutional investors and hedge funds own 83.55% of the company’s stock.
Several research analysts have recently issued reports on CME shares. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating in a research note on Wednesday, March 8th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $128.00 target price on shares of CME Group in a research note on Saturday, March 11th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $134.00 target price on shares of CME Group in a research note on Thursday, March 30th. Finally, Deutsche Bank AG reduced their target price on shares of CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a research note on Thursday, April 6th. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company’s stock. CME Group has a consensus rating of “Hold” and a consensus price target of $116.88.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.